Effects of a gamma-secretase inhibitor in a randomized study of patients with Alzheimer disease.
Siemers ER, Quinn JF, Kaye J, Farlow MR, Porsteinsson A, Tariot P, Zoulnouni P, Galvin JE, Holtzman DM, Knopman DS, Satterwhite J, Gonzales C, Dean RA, May PC.
Siemers ER, et al.
Neurology. 2006 Feb 28;66(4):602-4. doi: 10.1212/01.WNL.0000198762.41312.E1.
Neurology. 2006.
PMID: 16505324
Clinical Trial.